All Stories

  1. ESC Working Group on Cellular Biology of the Heart
  2. Extracellular vesicles in diagnostics and therapy of the ischaemic heart: Position Paper from the Working Group on Cellular Biology of the Heart of the European Society of Cardiology
  3. Position Paper of the European Society of Cardiology Working Group Cellular Biology of the Heart: cell-based therapies for myocardial repair and regeneration in ischemic heart disease and heart failure
  4. Intramyocardial stem cell injection: go(ne) with the flow
  5. Gelatin Microspheres as Vehicle for Cardiac Progenitor Cells Delivery to the Myocardium
  6. Cardiac Stem Cell Treatment in Myocardial InfarctionNovelty and Significance
  7. Cardiac derived ECM enhances cardiogenic properties of Human Cardiac Progenitor Cells
  8. Increased local delivery of antagomir therapeutics to the rodent myocardium using ultrasound and microbubbles
  9. Cardiac Regeneration and microRNAs: Regulators of Pluripotency, Reprogramming, and Cardiovascular Lineage Commitment
  10. Xenotransplantation of Human Cardiomyocyte Progenitor Cells Does Not Improve Cardiac Function in a Porcine Model of Chronic Ischemic Heart Failure. Results from a Randomized, Blinded, Placebo Controlled Trial
  11. Corrigendum: Gap junctional protein Cx43 is involved in the communication between extracellular vesicles and mammalian cells
  12. Gap junctional protein Cx43 is involved in the communication between extracellular vesicles and mammalian cells
  13. Stem Cell Aging and Age-Related Cardiovascular Disease: Perspectives of Treatment by Ex-vivo Stem Cell Rejuvenation
  14. Epicardial application of cardiac progenitor cells in a 3D-printed gelatin/hyaluronic acid patch preserves cardiac function after myocardial infarction
  15. MicroRNA-132/212 family enhances arteriogenesis after hindlimb ischaemia through modulation of the Ras-MAPK pathway
  16. MicroRNA Therapeutics for Cardiac Regeneration
  17. A snapshot of genetic and epigenetic basis of arrhythmia and heart failure
  18. Traditional Chinese Medication Qiliqiangxin attenuates cardiac remodeling after acute myocardial infarction in mice
  19. Cardiac Allograft Vasculopathy: A Donor or Recipient Induced Pathology?
  20. Necrostatin-1 alleviates reperfusion injury following acute myocardial infarction in pigs
  21. Ultrasound and Microbubble-Induced Local Delivery of MicroRNA-Based Therapeutics
  22. Different types of cultured human adult Cardiac Progenitor Cells have a high degree of transcriptome similarity
  23. Novel therapeutic strategies for cardioprotection
  24. Targeted delivery of miRNA therapeutics for cardiovascular diseases: opportunities and challenges
  25. Wnt/β-Catenin Signaling during Cardiac Development and Repair
  26. Inhibition of miR-25 improves cardiac contractility in the failing heart
  27. Layer-Specific Radiofrequency Ultrasound-Based Strain Analysis in a Porcine Model of Ischemic Cardiomyopathy Validated by a Geometric Model
  28. Sustained Delivery of Insulin-Like Growth Factor-1/Hepatocyte Growth Factor Stimulates Endogenous Cardiac Repair in the Chronic Infarcted Pig Heart
  29. Drug Delivery: A Fast pH-Switchable and Self-Healing Supramolecular Hydrogel Carrier for Guided, Local Catheter Injection in the Infarcted Myocardium (Adv. Healthcare Mater. 1/2014)
  30. Expanding Mouse Ventricular Cardiomyocytes Through GSK-3 Inhibition
  31. Concise Review: Engineering Myocardial Tissue: The Convergence of Stem Cells Biology and Tissue Engineering Technology
  32. Assessment of coronary microvascular resistance in the chronic infarcted pig heart
  33. A Fast pH-Switchable and Self-Healing Supramolecular Hydrogel Carrier for Guided, Local Catheter Injection in the Infarcted Myocardium
  34. Targeting cell death in the reperfused heart: Pharmacological approaches for cardioprotection
  35. microRNA-1 enhances the angiogenic differentiation of human cardiomyocyte progenitor cells
  36. SUSTAINED DELIVERY OF INSULIN-LIKE GROWTH FACTOR-1/HEPATOCYTE GROWTH FACTOR PROMOTES ENDOGENOUS CARDIAC REPAIR AND REGENERATION IN THE CHRONIC ISCHEMIC HEART
  37. Lack of haptoglobin results in unbalanced VEGFα/angiopoietin-1 expression, intramural hemorrhage and impaired wound healing after myocardial infarction
  38. MicroRNAs in Cardiovascular Regenerative Medicine: Directing Tissue Repair and Cellular Differentiation
  39. MicroRNA-204 is required for differentiation of human-derived cardiomyocyte progenitor cells
  40. Transendocardial cell injection is not superior to intracoronary infusion in a porcine model of ischaemic cardiomyopathy: a study on delivery efficiency
  41. Early assessment of acute coronary syndromes in the emergency department: the potential diagnostic value of circulating microRNAs
  42. MiR‐155 inhibits cell migration of human cardiomyocyte progenitor cells (hCMPCs) via targeting of MMP‐16
  43. Human cardiomyocyte progenitor cells: a short history of nearly everything
  44. Inhibition of RIP1-dependent necrosis prevents adverse cardiac remodeling after myocardial ischemia–reperfusion in vivo
  45. Sequential use of human-derived medium supplements favours cardiovascular tissue engineering
  46. Cardiac tissue engineering using tissue printing technology and human cardiac progenitor cells
  47. Cellular Therapy for the Infarcted Myocardium
  48. Letter by Sluijter et al Regarding Article, “Human Cardiac Stem Cell Differentiation Is Regulated by a Mircrine Mechanism”
  49. Decreased Mechanical Properties of Heart Valve Tissue Constructs Cultured in Platelet Lysate as Compared to Fetal Bovine Serum
  50. CLINICAL RELEVANCE OF ISCHEMIC LARGE ANIMAL MODELS IN STEM CELL THERAPY; AN OVERVIEW AND META-ANALYSIS.
  51. Tissue Engineering for Cardiac Regeneration
  52. Environmental regulation of valvulogenesis: implications for tissue engineering
  53. Non-surgical stem cell delivery strategies and in vivo cell tracking to injured myocardium
  54. MicroRNA-155 prevents necrotic cell death in human cardiomyocyte progenitor cells via targeting RIP1
  55. Cardiospheres and tissue engineering for myocardial regeneration: potential for clinical application
  56. Active Wnt signaling in response to cardiac injury
  57. Platelet-Lysate as an Autologous Alternative for Fetal Bovine Serum in Cardiovascular Tissue Engineering
  58. Hyperpolarization Induces Differentiation in Human Cardiomyocyte Progenitor Cells
  59. Foetal and adult cardiomyocyte progenitor cells have different developmental potential
  60. Human cardiomyocyte progenitor cell-derived cardiomyocytes display a maturated electrical phenotype
  61. Cell Therapy for Myocardial Regeneration
  62. The Potential of Modulating Small RNA Activity In Vivo
  63. Human cardiomyocyte progenitor cells differentiate into functional mature cardiomyocytes: an in vitro model for studying human cardiac physiology and pathophysiology
  64. Stem Cells from In- or Outside of the Heart: Isolation, Characterization, and Potential for Myocardial Tissue Regeneration
  65. Caveolin-1 Influences Vascular Protease Activity and Is a Potential Stabilizing Factor in Human Atherosclerotic Disease
  66. TGF-β1 induces efficient differentiation of human cardiomyocyte progenitor cells into functional cardiomyocytes in vitro
  67. Balance between Angiopoietin-1 and Angiopoietin-2 Is in Favor of Angiopoietin-2 in Atherosclerotic Plaques with High Microvessel Density
  68. Isolation and expansion of resident cardiac progenitor cells
  69. Vascular remodeling and protease inhibition—bench to bedside
  70. Quantitative Real-Time PCR
  71. Modulation of Collagen Turnover in Cardiovascular Disease
  72. Increase in Collagen Turnover But Not in Collagen Fiber Content Is Associated with Flow-Induced Arterial Remodeling
  73. Furin and membrane type-1 metalloproteinase mRNA levels and activation of metalloproteinase-2 are associated with arterial remodeling